Large-Scale Transcriptome Profiling and Network Pharmacology Analysis Reveal the Multi-Target Inhibitory Mechanism of Modified Guizhi Fuling Decoction in Prostate Cancer Cells
Pharmaceuticals · 27.08.2025 · 18 (9) · 1275
DOI: 10.3390/ph18091275 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 27.08.2025. Verfasst von Guochen Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan Provincial Administration of Traditional Chinese Medicine, Key Projects of Science and Technology Plan of Inner Mongolia Autonomous Region, Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Background
Prostate cancer (PCa) is the primary contributor to male cancer-related mortality and currently lacks effective treatment options. The Modified Guizhi Fuling Decoction (MGFD) is used in clinical practice to treat multiple tumors. This research focused on the mechanisms of action (MOA) in MGFD that inhibit PCa.
Methods
The impact of MGFD on PCa cells (PC3 and DU145) was examined via Cell Counting Kit-8, wound healing assays, and transwell assays. To determine the MOA, high-throughput sequencing based high-throughput screening (HTS2) was utilized along with network pharmacology.
Results
The findings indicated that MGFD suppressed the proliferation, migration, and invasion of PCa cells. We then utilized the HTS2 assay to generate 270 gene expression profiles from PCa cells perturbed by MGFD. Large-scale transcriptional analysis highlighted three pathways closely associated with PCa: the TNF signaling pathway, cellular senescence, and FoxO signaling pathway. Through the combination of network pharmacology and bioinformatics, we discovered four primary targets through which MGFD acts on PCa: AKT serine/threonine kinase 1 (AKT1), Caspase-8 (CASP8), Cyclin-Dependent Kinase 1 (CDK1), and Cyclin D1 (CCND1). Finally, molecular docking demonstrated that the potential bioactive compounds baicalein, quercetin, and 5-[[5-(4-methoxyphenyl)-2-furyl] methylene] barbituric acid strongly bind to CDK1, AKT1, and CASP8, respectively.
Conclusions
This research shows that MGFD displays encouraging anticancer effects via various mechanisms. Its multi-target activity profile underscores its promise as a potential therapeutic option for PCa treatment and encourages additional in vivo validation studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
- LKS Faculty of Medicine, School of Chinese Medical, The University of Hong Kong, Hong Kong 999077, China.
- Medical Innovation Center for Nationalities, Inner Mongolia Medical University, Hohhot City 010110, China.
ORCID-Profile: Yan Luo, Jianping Chen, Dong Wang
Förderung
- Sichuan Provincial Administration of Traditional Chinese Medicine
- Key Projects of Science and Technology Plan of Inner Mongolia Autonomous Region
- Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
Zitieren
APA
Zhang, G., Xiang, L., Li, Q., Wei, M., Yu, X., Luo, Y., Chen, J., Bao, X., Wang, D., & Zhou, S. (2025). Large-Scale Transcriptome Profiling and Network Pharmacology Analysis Reveal the Multi-Target Inhibitory Mechanism of Modified Guizhi Fuling Decoction in Prostate Cancer Cells. Pharmaceuticals, 18(9), 1275. https://doi.org/10.3390/ph18091275
Vancouver
Zhang G, Xiang L, Li Q, Wei M, Yu X, Luo Y, et al. Large-Scale Transcriptome Profiling and Network Pharmacology Analysis Reveal the Multi-Target Inhibitory Mechanism of Modified Guizhi Fuling Decoction in Prostate Cancer Cells. Pharmaceuticals. 2025;18(9):1275. doi:10.3390/ph18091275
BibTeX
@article{Zhang2025,
author = {Zhang, Guochen and Xiang, Lei and Li, Qingzhou and Wei, Mingming and Yu, Xiankuo and Luo, Yan and Chen, Jianping and Bao, Xilinqiqige and Wang, Dong and Zhou, Shiyi},
title = {Large-Scale Transcriptome Profiling and Network Pharmacology Analysis Reveal the Multi-Target Inhibitory Mechanism of Modified Guizhi Fuling Decoction in Prostate Cancer Cells},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {9},
pages = {1275},
doi = {10.3390/ph18091275}
}
EUVIMED